Skip to content

Validation of a Plasma-based Multiomics assay and Risk Scoring Model for Screening of Gastric Malignancies

Validation of a Plasma-based Multiomics assay and Risk Scoring Model for Screening of Gastric Malignancies

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047645
Enrollment
Unknown
Registered
2021-06-21
Start date
2021-06-16
Completion date
Unknown
Last updated
2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Gold Standard:Pathological diagnosis
Index test:Diagnostic&#32
model&#32
of&#32
cancer&#32
based&#32
on&#32
multi-analytic&#32

Sponsors

Department of Endoscopy, Cancer Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 88 Years

Inclusion criteria

Inclusion criteria: 1. Age >= 40 years old; 2. Received gastroscopy; 3. Subjects must have given written informed consent, and the subject's compliance is good.

Exclusion criteria

Exclusion criteria: 1. Subjects who could not accept gastroscopy; 2. Subjects who had previously undergone total or partial gastrectomy; 3. There are other serious acute or chronic medical or mental diseases or laboratory abnormalities that may interfere with the interpretation of the research results and make the subjects unsuitable for the study in the judgment of the researchers; 4. Subjects with a history of malignant tumor or two or more malignant tumors at the same time; 5. Pregnant subjects; 6. Subjects who had a history of bone marrow or organ transplantation, or had a history of blood transfusion one month before enrollment; 7. The subjects with incomplete clinical data collection or other reasons judged by the researchers are not suitable for this study.

Design outcomes

Primary

MeasureTime frame
Target gene capturesequencing;ctDNA methylation;Low-pass WGS;

Countries

China

Contacts

Public ContactYao Fang

Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical college

yaofang99@sina.com+86 13511073309

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026